Hofseth Biocare ASA
OSE:HBC

Watchlist Manager

Hofseth Biocare ASA

OSE:HBC

Watchlist

Dividends

Discount Rate

Price: 1.305 NOK -0.76% Market Closed

Market Cap: 515.6m NOK

Have any thoughts about
Hofseth Biocare ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 1.305 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

HBC Alert

Hofseth Biocare ASA

1.305

-0.010 (-0.76%)

52 Week Range	1.29 2.82
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Hofseth Biocare ASA

What unique competitive advantages
does Hofseth Biocare ASA hold over its rivals?

What risks and challenges
does Hofseth Biocare ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Hofseth Biocare ASA.

What unique competitive advantages
does Hofseth Biocare ASA hold over its rivals?

What risks and challenges
does Hofseth Biocare ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hofseth Biocare ASA.

Provide P/S
for Hofseth Biocare ASA.

Provide P/E
for Hofseth Biocare ASA.

Provide P/OCF
for Hofseth Biocare ASA.

Provide P/FCFE
for Hofseth Biocare ASA.

Provide P/B
for Hofseth Biocare ASA.

Provide EV/S
for Hofseth Biocare ASA.

Provide EV/GP
for Hofseth Biocare ASA.

Provide EV/EBITDA
for Hofseth Biocare ASA.

Provide EV/EBIT
for Hofseth Biocare ASA.

Provide EV/OCF
for Hofseth Biocare ASA.

Provide EV/FCFF
for Hofseth Biocare ASA.

Provide EV/IC
for Hofseth Biocare ASA.

What are the Revenue projections
for Hofseth Biocare ASA?

How accurate were the past Revenue estimates
for Hofseth Biocare ASA?

What are the Net Income projections
for Hofseth Biocare ASA?

How accurate were the past Net Income estimates
for Hofseth Biocare ASA?

What are the EPS projections
for Hofseth Biocare ASA?

How accurate were the past EPS estimates
for Hofseth Biocare ASA?

What are the EBIT projections
for Hofseth Biocare ASA?

How accurate were the past EBIT estimates
for Hofseth Biocare ASA?

Compare the revenue forecasts
for Hofseth Biocare ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hofseth Biocare ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hofseth Biocare ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hofseth Biocare ASA compared to its peers.

Compare the P/E ratios
of Hofseth Biocare ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Hofseth Biocare ASA with its peers.

Analyze the financial leverage
of Hofseth Biocare ASA compared to its main competitors.

Show all profitability ratios
for Hofseth Biocare ASA.

Provide ROE
for Hofseth Biocare ASA.

Provide ROA
for Hofseth Biocare ASA.

Provide ROIC
for Hofseth Biocare ASA.

Provide ROCE
for Hofseth Biocare ASA.

Provide Gross Margin
for Hofseth Biocare ASA.

Provide Operating Margin
for Hofseth Biocare ASA.

Provide Net Margin
for Hofseth Biocare ASA.

Provide FCF Margin
for Hofseth Biocare ASA.

Show all solvency ratios
for Hofseth Biocare ASA.

Provide D/E Ratio
for Hofseth Biocare ASA.

Provide D/A Ratio
for Hofseth Biocare ASA.

Provide Interest Coverage Ratio
for Hofseth Biocare ASA.

Provide Altman Z-Score Ratio
for Hofseth Biocare ASA.

Provide Quick Ratio
for Hofseth Biocare ASA.

Provide Current Ratio
for Hofseth Biocare ASA.

Provide Cash Ratio
for Hofseth Biocare ASA.

What is the historical Revenue growth
over the last 5 years for Hofseth Biocare ASA?

What is the historical Net Income growth
over the last 5 years for Hofseth Biocare ASA?

What is the current Free Cash Flow
of Hofseth Biocare ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hofseth Biocare ASA.

EV/EBITDA
Enterprise Value to EBITDA

-6.9

Current

-14.5

Median

4.2

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-6.9

Enterprise Value

606.9m NOK

EBITDA

-87.2m NOK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
NO		Hofseth Biocare ASA OSE:HBC	536.5m NOK	-6.9
FR		Pharnext SCA OTC:PNEXF	6T USD	-218 147.8
US		Abbvie Inc NYSE:ABBV	325.5B USD	15.8
US		Amgen Inc NASDAQ:AMGN	150.4B USD	16.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	120.9B USD	25.1
US		Gilead Sciences Inc NASDAQ:GILD	115.7B USD	10.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-517.9
AU		CSL Ltd ASX:CSL	135.7B AUD	20.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	83.7B USD	16.4
US	S	Seagen Inc F:SGT	39.3B EUR	-59.2
NL		argenx SE XBRU:ARGX	34.6B EUR	-105.5

				EBITDA Growth
NO		Hofseth Biocare ASA OSE:HBC	Average EV/EBITDA: 17.5 Negative Multiple: -6.9	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -218 147.8	N/A
US		Abbvie Inc NYSE:ABBV	15.8	29%
US		Amgen Inc NASDAQ:AMGN	16.8	62%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	25.1	43%
US		Gilead Sciences Inc NASDAQ:GILD	10.2	16%
US	E	Epizyme Inc F:EPE	Negative Multiple: -517.9	N/A
AU		CSL Ltd ASX:CSL	20.5	42%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	16.4	35%
US	S	Seagen Inc F:SGT	Negative Multiple: -59.2	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -105.5	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

Hofseth Biocare ASA
OSE:HBC

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Hofseth Biocare ASA OSE:HBC

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Hofseth Biocare ASA
OSE:HBC

EV/EBITDA
Enterprise Value to EBITDA